CAS 62952-06-1

Aspisol

Description:

Aspisol, with the CAS number 62952-06-1, is a chemical compound primarily known for its application in the pharmaceutical industry, particularly as a non-steroidal anti-inflammatory drug (NSAID). It exhibits analgesic, antipyretic, and anti-inflammatory properties, making it useful for treating pain, fever, and inflammation. Aspisol functions by inhibiting the cyclooxygenase (COX) enzymes, which play a crucial role in the synthesis of prostaglandins, compounds that mediate inflammation and pain. The substance is typically administered in various formulations, including tablets and topical applications, and is characterized by its relatively low toxicity profile compared to other NSAIDs. However, like all medications, it may have side effects, including gastrointestinal discomfort and potential cardiovascular risks, particularly with long-term use. Its pharmacokinetics involve absorption, distribution, metabolism, and excretion processes that are essential for determining its efficacy and safety in clinical use. Overall, Aspisol is a significant compound in the realm of pain management and inflammation control.

Formula: C₉H₈O₄·C₆H₁₄N₂O₂

InChI: InChI=1S/C9H8O4.C6H14N2O2/c1-6(10)13-8-5-3-2-4-7(8)9(11)12;7-4-2-1-3-5(8)6(9)10/h2-5H,1H3,(H,11,12);5H,1-4,7-8H2,(H,9,10)

InChI key: InChIKey=JJBCTCGUOQYZHK-UHFFFAOYSA-N

SMILES: C(CCCCN)(C(O)=O)N.C(O)(=O)C1=C(OC(C)=O)C=CC=C1

Synonyms:

• 2,6-Diaminohexanoic Acid Compound With 2-Acetoxybenzoic Acid (1:1)
• 6-Ammonionorleucine 2-(Acetyloxy)Benzoate
• <span class="text-smallcaps">DL</span>-Lysine acetylsalicylate
• <span class="text-smallcaps">DL</span>-Lysine aspirin salt
• <span class="text-smallcaps">DL</span>-Lysine, mono[2-(acetyloxy)benzoate]
• Acelysin
• Acelysine
• Acetylsalicylic acid <span class="text-smallcaps">DL</span>-lysine salt
• Acetylsalicylic acid dl-lysine salt
• Acetylsalicylic acid lysine salt
• Asalis
• Aspegic
• Aspidol
• Aspirin <span class="text-smallcaps">D</smallcap><smallcap>L</span>-lysine
• Aspirin DL-lysine
• Aspirin Lysine
• Aspirin lysine salt
• Aspirisine
• Aspisol
• Atselizin
• Benzoic acid, 2-(acetyloxy)-, compd. with <span class="text-smallcaps">DL</span>-lysine (1:1)
• Benzoic acid, 2-(acetyloxy)-, compd. with lysine (1:1)
• Cogla
• DL-Lysine acetylsalicylate
• Delgesic
• Egicalm
• Laboprin
• Lysal
• Lysine acetylsalicylate
• Lysine monosalicylate acetate
• Lysine, 2-(acetyloxy)benzoate (1:1)
• Lysine, mono[2-(acetyloxy)benzoate]
• Lysini racemici acetylsalicylase
• Quinvet
• Solpirin
• Venopirin
• Vetalgina
• Vetalgine
• o-Acetylsalicylic acid <span class="text-smallcaps">D</smallcap>,<smallcap>L</span>-lysine salt
• DL-Lysine, mono[2-(acetyloxy)benzoate]

DL-LYSINE ACETYLSALICYLATE CRS

CAS: 62952-06-1

DL-LYSINE ACETYLSALICYLATE CRS

Ref: 41-Y0002211

DL-Lysine Acetylsalicylate

CAS: 62952-06-1

Formula: C₁₅H₂₂N₂O₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 326.3450

Ref: IN-DA01CC6I

DL-Lysine Acetylsalicylate

CAS: 62952-06-1

Formula: C₉H₈O₄·C₆H₁₄N₂O₂

Purity: >98.0%(T)(HPLC)

Color and Shape: White to Light yellow powder to crystal

Molecular weight: 326.35

Ref: 3B-A3744

DL-Lysine Acetylsalicylate

Controlled Product

CAS: 62952-06-1

Applications Non-steroidal anti-inflammatory drugs (NSAIDs) may inhibit cancer growth. Water soluble, injectable aspirin derivative.Analgesic; antipyretic; anti-inflammatory.
References Korttila, K., et al.: Br. J. Anaesth, 52, 613 (1980), Diaz, C., et al.: Clin. Ther., 4, 121 (1981), Wolff, F., et al.: Arch. Gynecol., 233, 15 (1982), Bretagne, J.-F., et al.: Gastroenterol. Clin. Biol., 8, 28 (1984),

Formula: C₉H₈O₄·C₆H₁₄N₂O₂

Color and Shape: Neat

Molecular weight: 326.34

Ref: TR-L488500

Aspirin DL-lysine

CAS: 62952-06-1

Aspirin DL-lysine: a water-soluble, injectable NSAID that may also hinder cancer growth.

Formula: C₁₅H₂₂N₂O₆

Color and Shape: Crystalline Solid

Molecular weight: 326.35

Ref: TM-T20458

DL-Lysine acetylsalicylate

CAS: 62952-06-1

L-Lysine acetylsalicylate is a nonsteroidal anti-inflammatory drug that has been shown to have analgesic and anti-inflammatory properties. L-Lysine acetylsalicylate has been shown to inhibit the activity of the enzyme cyclooxygenase, which is responsible for the production of prostaglandins from arachidonic acid. This inhibition leads to decreased levels of prostaglandins and a decrease in inflammation. L-Lysine acetylsalicylate also inhibits the activity of platelets, which are necessary for blood clotting. It does not affect the brain infarction process, but does increase cerebral blood flow in glioma patients. L-Lysine acetylsalicylate has been shown to be an effective treatment against cervical cancer cells in cell culture experiments. The molecular weight of this compound is 584 Da and it contains 8 atoms of oxygen that can be replaced with chloride ions or acet

Formula: C₉H₈O₄•C₆H₁₄N₂O₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 326.35 g/mol

Ref: 3D-FL24964